The umbrella partnership C corporation (Up-C) structure has been a popular option for pass-through entities looking to gain access to the capital markets.
Inevitably, companies looking to go public will face the prospect of comment letters from the Securities and Exchange Commission (SEC).
Time is running out for any remaining companies to implement the latest ASC 606 revenue recognition standard.
Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.
The sell-side quality-of-earnings (QoE) report has become a critical piece of any private equity transaction.
Through hard work and dedication, Angela Barcelos has made a name for herself at CFGI and in the broader financial industry.